Scutellaria baicalensis extract prevents metabolic dysfunction-associated steatotic liver disease by modulating the gut-liver axis in high-fat diet mice
Phytochemistry · 2026
DOI: 10.1016/j.phytochem.2025.114720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemistry, 2026. Verfasst von Liting Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, 130117, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Scutellaria baicalensis, Liver, Fatty Liver, Plant Extracts. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
Emerging evidence indicates that metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly associated with gut microbial dysbiosis and disruption of the intestinal mucosal barrier function. Scutellaria baicalensis extract (SBE) has anti-inflammatory and hepatoprotective effects. In this study, the investigation conducted explored whether SBE can alleviate MASLD and the possible mechanism involving the gut-liver axis. Qualitative and quantitative analyses of SBE using UPLC-Q-Orbitrap-MS and UPLC-QqQ-MS revealed that the major component of SBE was Baicalin, which accounted for approximately 94.12 %. A mice model of MASLD was established by feeding mice a high-fat diet (HFD) and administering SBE intragastrically. The effects of SBE on liver biochemical parameters, intestinal histopathology, intestinal integrity, and gut microbiota were evaluated. SBE restored the expression of TJs in the intestine and ameliorated the increased permeability of the intestinal mucosa induced by the HFD, thereby enhancing the function of the intestinal barrier. In addition, SBE altered the composition of the gut microbiota in mice with MASLD, decreasing the abundance of Helicobacter and increasing the abundance of Bacteroidota. The results of fecal metabolomics showed that medium-dose SBE significantly upregulated the levels of 11 metabolites, including cholic acid, and downregulated the levels of 13 metabolites, including allantoic acid. Moreover, SBE may reverse HFD-induced hepatic steatosis in mice, suggesting that SBE could serve as a potential therapeutic strategy for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Changchun University of Chinese Medicine, 130117, Changchun, Jilin, China.
- Changchun University of Chinese Medicine, 130117, Changchun, Jilin, China. Electronic address: zhengfei@ccucm.edu.cn.
- Changchun University of Chinese Medicine, 130117, Changchun, Jilin, China. Electronic address: yuehao@ccucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology of Jilin Province
Zitieren
APA
Ma, L., Wang, Y., Ren, T., Pan, L., Li, X., Wang, S., Li, D., Zhang, M., Li, F., Zheng, F., & Yue, H. (2026). Scutellaria baicalensis extract prevents metabolic dysfunction-associated steatotic liver disease by modulating the gut-liver axis in high-fat diet mice. Phytochemistry. https://doi.org/10.1016/j.phytochem.2025.114720
Vancouver
Ma L, Wang Y, Ren T, Pan L, Li X, Wang S, et al. Scutellaria baicalensis extract prevents metabolic dysfunction-associated steatotic liver disease by modulating the gut-liver axis in high-fat diet mice. Phytochemistry. 2026. doi:10.1016/j.phytochem.2025.114720
BibTeX
@article{Ma2026,
author = {Ma, Liting and Wang, Yizhu and Ren, Tao and Pan, Lijia and Li, Xinze and Wang, Shen and Li, Dihao and Zhang, Meiyu and Li, Fangtong and Zheng, Fei and Yue, Hao},
title = {Scutellaria baicalensis extract prevents metabolic dysfunction-associated steatotic liver disease by modulating the gut-liver axis in high-fat diet mice},
journal = {Phytochemistry},
year = {2026},
doi = {10.1016/j.phytochem.2025.114720}
}
EUVIMED